Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Lymphoma × Surveys and Questionnaires × Clear all

Status

Completed 6 Terminated 3 Recruiting 3 Unknown 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Recurrence 2 Neoplasm Metastasis 2 Head and Neck Neoplasms 2 cyclopia sequence 1 Sezary Syndrome 1 Seroma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polyneuropathies 1 Peripheral Nervous System Diseases 1 Patient Education 1 Pain 1 Ovarian Neoplasms 1 Occupational Stress 1 Neoplasms, Plasma Cell 1 Mycosis Fungoides 1 Mouth Neoplasms 1 Mesothelioma 1 Malignant Neoplasms of Independent (Primary) Multiple Sites 1 Malignant Neoplasms of Female Genital Organs 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma 1 Lung Diseases 1 Glioblastoma 1 Esophageal Neoplasms 1 Dyspnea 1

Interventions

Rituximab 17 Cyclophosphamide 15 fludarabine phosphate 9 Filgrastim 9 Etoposide 9 Vincristine 8 Radiotherapy 8 Peripheral Blood Stem Cell Transplantation 8 Doxorubicin 8 Prednisone 7 Methotrexate 7 Melphalan 6 Cytarabine 6 Dexamethasone 5 fludarabine 4 Cyclosporine 4 Antilymphocyte Serum 4 duvelisib 3 Thiotepa 3 Tacrolimus 3 Nivolumab 3 Mycophenolic Acid 3 Ifosfamide 3 Gemcitabine 3 Busulfan 3 Alemtuzumab 3 sargramostim 2 pembrolizumab 2 ofatumumab 2 ibrutinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00488553 2012-02-24

Molecular Epidemiology of Lymphoma Patients

M.D. Anderson Cancer Center

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡